Nebraska Attorney General Mike Hilgers has joined the Federal Trade Commission and several states in a lawsuit against telehealth provider…
Nebraska Attorney General Mike Hilgers has joined the FTC and four other states in a lawsuit against telehealth provider Hims…
The lawsuit alleges the telehealth company shared sensitive health information with advertisers and misled customers about charges and subscriptions.…
Key TakeawaysEli Lilly now sells Zepbound and Foundayo directly on Hims & Hers at its own self-pay prices, joining Novo…
Hims & hers slides 4.37% today to $19.90 after missing Q3 forecasts, with bearish momentum and technical pressure persisting.…
Needham’s math needs the subscribers back first…
Hims & Hers stock sank after a Q3 earnings and revenue miss, lower EBITDA guidance, subscriber declines, and an expanding…
Hims & Hers Health surges 8.73% today to $20.81 amid mixed earnings, new board member, and regulatory news.…
This month Hims & Hers adds Tonal, Grüns, Viome and Medjet perks to benefits for GLP-1 subscribers seeking fitness and…
The lawsuit alleges the company shared consumers sensitive health information with third-party advertising platforms including Meta Platforms and Snap, despite…
Hims & Hers Health faces mounting legal pressure after five additional US states joined a Federal Trade Commission lawsuit accusing…
Filing alleges Hims uploaded 14 million consumer emails to Meta; counts against the telehealth firm go from 9 to 16.…
Hims & Hers Health missed Q3 estimates, subscribers fell QoQ, and gross margin declined to a new low. See why…
Hims & Hers Health, Inc., is a Hold: Q3 growth excluding Eucalyptus was 26%. Click for this HIMS stock earnings…
Hims & Hers is bouncing back after a brutal selloff, yet the legal heat keeps rising and its two biggest…
Hims & Hers is bouncing back after a brutal selloff, yet the legal heat keeps rising and its two biggest…
HIMS shares dip nearly 3% after Q3 earnings and revenue miss, a sharp gross margin contraction and lower 2026 adjusted…
Hims & Hers Health, Inc. HIMS reported quarterly earnings per share (EPS) of 3 cents in third-quarter 2026, down from the…
Business Chief ranks 10 CEOs in Healthcare & Healthtech including Chaim Indig of Phreesia, Andrew Dudum of Hims & Hers…
The Buckeye state is joined by four other states in signing on to the suit.…
Hims & Hers Health surges 3.29% today to $19.77, on strong Q3 revenue growth and partnerships, despite bearish market trends.…
Reported a Q3 loss of 14 cents per share, missing the 8-cent consensus estimate. Revenue rose 49% YoY to $890.373…
Hims & Hers Health Inc. (NYSE: HIMS) had a busy week that included Q3 earnings miss, a board appointment and…
The Federal Trade Commission first sued the telehealth company in July for allegedly sharing consumers health data with advertisers.…
Hims & Hers (HIMS) remained on investors’ radar on Wednesday, with KeyBanc saying 2026 could be a transition year for…
Analyst Justin Patterson said Hims & Hers’ focus on lower treatment prices could eventually attract more subscribers and increase the…
Analyst Justin Patterson said Hims & Hers’ focus on lower treatment prices could eventually attract more subscribers and increase the…
Hims & Hers Health reported third-quarter 2026 revenue of $890.4 million, up 49% from $599 million a year earlier, as…
Hims & Hers Health Inc. NYSE:HIMS rose 1.36% in premarket as KeyBanc reiterated its Sector Weight rating, with analyst Justin…
On November 10, 2026, the Federal Trade Commission announced that it had filed an amended complaint adding Arizona, Florida, Nebraska,…
Hims and Hers stock rating held at Sector Weight by KeyBanc…
Hims and Hers stock rating held at Sector Weight by KeyBanc…
Five states - Arizona, Florida, Nebraska, Ohio and Wisconsin - joined a Federal Trade Commission lawsuit accusing Hims & Hers…
Hims & Hers Health ($HIMS) is facing legal troubles as five U.S. states joined the Federal Trade Commission (FTC) in…
Hims & Hers trades at $19.13 today after sliding 16.59%. Regulatory worries and weak earnings pressure the stock further.…
By Kanishka Singh WASHINGTON, Nov 10 (Reuters) - Five US states have joined the Federal Trade Commission in a lawsuit…
By Kanishka Singh WASHINGTON, Nov 10 (Reuters) - Five US states have joined the Federal Trade Commission in a lawsuit…
Hims & Hers Health just watched its stock get hit hard. The shares closed at US$22.94 before the Q3 2026…
The telehealth provider projects full-year 2026 revenue of $3.13 billion to $3.15 billion and narrowed its EBITDA guidance.…
The US FTC filed an amended complaint in court adding Arizona, Florida, Nebraska, Ohio and Wisconsin as co-plaintiffs in its…
Hims & Hers stock just fell 16.5% to about US$19 in regular trading, wiping out a chunk of short term…
Five US states join FTC suit over alleged Hims & Hers unlawful practices…
WASHINGTON, Nov 10 () - Five US ?states have ?joined the Federal Trade Commission in a lawsuit that alleges telehealth…
WASHINGTON, Nov 10 (Reuters) - Five US states have joined the Federal Trade Commission in a lawsuit that alleges telehealth…
By Kanishka Singh WASHINGTON, Nov 10 (Reuters) - Five US states have joined the Federal Trade Commission in a lawsuit…
By Kanishka Singh WASHINGTON, Nov 10 (Reuters) - Five US states have joined the Federal Trade Commission in a lawsuit…
Washington, Nov 10 - Five US states have joined the Federal Trade Commission in a lawsuit that alleges telehealth company…
Digital health and wellness company Hims & Hers tightened its full-year 2026 revenue outlook after…
Hims & Hers Health maintains robust growth prospects despite a minor Q326 revenue miss, leading to a market overreaction. Read…
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage…